Contrast-enhanced MRI revealed a significantly higher myocardial fibrosis index in patients with primary aldosteronism compared to healthy controls (0.43 vs. 0.36; P=0.002).
Case-Control (n=37)
Is the degree of myocardial fibrosis and left ventricular chamber stiffness increased in patients with primary aldosteronism compared to healthy volunteers?
Patients with primary aldosteronism have an increased MRI-derived fibrosis index, which correlates with impaired left ventricular diastolic function.
Absolute Event Rate: 0.43% vs 0.36%
p-value: p=0.002
PURPOSE: To assess the degree of myocardial fibrosis in patients with primary aldosteronism (PA). MATERIALS AND METHODS: Twenty-five patients with PA and 12 age-matched healthy volunteers underwent cine and late gadolinium enhancement (LGE) magnetic resonance imaging (MRI) on a 1.5 T MR system. From volume-time curves of cine MRI, the time for deceleration (Tdec) was determined to assess the left ventricle (LV) chamber stiffness. Based on phase-sensitive reconstructed LGE images, a fibrosis index called enhancement value (EV) was computed as the signal intensity change in the myocardium over blood before and after contrast. Both Tdec and EV were compared between patients and controls. The association between Tdec and EV was investigated. RESULTS: Patients showed a significantly higher EV (0.43 ± 0.05 vs. 0.36 ± 0.07; P = 0.002) and a significantly shorter Tdec (11.5 ± 3.5 %RR vs. 15.3 ± 2.4 %RR; P = 0.004) than controls. Significant correlations between EV and Tdec were observed in patients (r = -0.46, P = 0.018), in controls (r = -0.68, P = 0.015) and in all subjects (r = -0.63, P < 0.001). CONCLUSION: The fibrosis index is increased in patients with PA and the increase imposes an adverse effect on LV diastolic function.
Su et al. (2012) conducted a case-control in Primary aldosteronism (n=37). Contrast-enhanced MRI vs. Healthy volunteers was evaluated on Enhancement value (EV) as a fibrosis index (p=0.002). Contrast-enhanced MRI revealed a significantly higher myocardial fibrosis index in patients with primary aldosteronism compared to healthy controls (0.43 vs. 0.36; P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: